ALR Technologies Inc. (ALRT) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Health-e-Connect (HeC) System for remote monitoring of patients in support of effective diabetes management programs.
Sidney Chan, Company CEO, commented:
“We are pleased to reach this milestone and are eager to introduce to market this cross-platform technology. The HeC System represents a breakthrough for clinician/patient communication to enhance disease management and improve health outcomes. The System provides the potential to achieve significant savings to the US healthcare system through enhanced adherence to care plans. In anticipation of the FDA clearance, we have been cultivating relationships with manufacturers of diabetes test supplies and insurance companies to help facilitate a successful launch.”
ALRT stock traded over 20fold of its 10day average volume with posted gain of 80%.
3350 Riverwood Pkwy, Suite 1900
Atlanta, Georgia 30399
ALR Technologies Inc. (ALR Tech) designs, markets and distributes technology-based products to help people achieve better health and well-being. These products include medication adminstration reminders and a web based patient monitoring system (HeC) intended to help optimize a patient’s health care plan and therapeutic benefit by improving compliance, communication and feedback.